Eli Lilly (LLY) Issus Near-, Mid-Term Outlook; Will Supplement Dividends with Buybacks
Tweet Send to a Friend
Eli Lilly & Co. (NYSE: LLY) expects to launch several new medicines to treat unmet patient needs beginning next year ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
